14 years ago

Veryan Medical Secures £5 Million Funding for Biomimicry-Based Vascular Solutions

  • Veryan Medical, a Horsham, UK-based developer of innovative solutions for vascular disease using the principles of biomimicry, has raised £5 million in funding

  • The round was led by Imperial Innovations Group plc, which holds a 48.4% stake in the company, and Seroba Kernel Life Sciences, with participation from Veryan Chairman Dr

  • Geoffrey Vernon

  • The investment follows a previous £3.6 million funding round in March 2010

  • Veryan has developed a proprietary stent technology, BioMimics 3D™, which aims to mimic the natural shape and geometry of the human vascular system.

      • ProblemHealthcare

      "People suffering from vascular disease need better stents. Current stents can cause blockages and damage to blood vessels, leading to further complications. "

      Solution

      "Veryan Medical has developed a unique stent technology called BioMimics 3D™ that mimics the natural shape and geometry of the human vascular system, reducing the risk of blockages and damage to blood vessels."

      Covered on